Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan Conditioning for Allogeneic SCT in Hematological Malignancies
NCT00129155Phase 2Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in chronic myeloid leukemia (CML), multiple myeloma (MM), non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), sponsored by Hospices Civils de Lyon. Status: unknown.
02
Drugs
treosulfan
03
Conditions
chronic myeloid leukemia (CML)multiple myeloma (MM)non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00129155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129155.